Modalis Therapeutics
4883.TTSE GROWTHPharmaceutical
Major holders (5%+) · 3
| Holder | Stake |
|---|---|
| Evo Fund | 7.61% |
| Life Science Innovation Management Inc. | 6.28% |
| LSIM Inc. | 5.02% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 5
| SBI SECURITIES Co., Ltd. | 3.77% |
| Osamu Nureki | 3.58% |
| SBI Investment Co., Ltd. | 0.69% |
| Haruhiko Morita | 0.38% |
| Evolution Capital Management LLC | 0.00% |
Ownership history · 177
| Holder | Ratio | Change |
|---|---|---|
| Evolution Capital Management LLC2026-06-19 · amended | 0.00% | no change |
| Evo Fund2026-06-19 · amended | 8.96% | -0.06pp |
| Evolution Capital Management LLC2026-06-19 · amended | 0.00% | no change |
| Evo Fund2026-06-19 · amended | 9.02% | -1.26pp |
| Evolution Capital Management LLC2026-06-19 · amended | 0.00% | no change |
| Evo Fund2026-06-19 · amended | 10.28% | -3.95pp |
| Evolution Capital Management LLC2026-06-19 · amended | 0.00% | no change |
| Evo Fund2026-06-19 · amended | 14.23% | -0.93pp |
| Evolution Capital Management LLC2026-06-19 · amended | 0.00% | no change |
| Evo Fund2026-06-19 · amended | 15.16% | -1.04pp |
| Evolution Capital Management LLC2026-06-19 · amended | 0.00% | no change |
| Evo Fund2026-06-19 · amended | 16.20% | -1.26pp |
| Evolution Capital Management LLC2026-06-19 · amended | 0.00% | no change |
| Evo Fund2026-06-19 · amended | 17.46% | -1.61pp |
| Evolution Capital Management LLC2026-06-19 · amended | 0.00% | no change |
| Evo Fund2026-06-19 · amended | 19.07% | -1.12pp |
| Evolution Capital Management LLC2026-06-19 · amended | 0.00% | no change |
| Evo Fund2026-06-19 · amended | 20.19% | -1.30pp |
| Evolution Capital Management LLC2026-06-19 · amended | 0.00% | no change |
| Evo Fund2026-06-19 · amended | 21.49% | -0.39pp |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.